Skip to main content
. Author manuscript; available in PMC: 2014 Feb 12.
Published in final edited form as: J Am Coll Cardiol. 2013 Feb 12;61(6):635–642. doi: 10.1016/j.jacc.2012.11.027

Table 1.

Baseline Patient Characteristics, N=758 (%)

Demographics
Age, years (mean, SD) 79.7 (6.2)
Age group
 65–74 170 (22.4)
 75–84 417 (55.0)
 >= 85 171 (22.6)
Female sex 383 (50.5)
Non-white race 97 (12.8)
Education < high school 270 (35.8)
Body mass index (kg/m2)
<18 23 (3.0)
18 – <25 329 (43.5)
25 – <30 270 (35.7)
≥ 30 135 (17.8)
Heart failure Status
Ejection fraction < 45% 203 (43.2)
New York Heart Association class
I 22 (3.2)
II 462 (66.5)
III 173 (24.9)
IV 38 (5.4)
ACE-inhibitor 257 (40.7)
Beta-blocker 99 (15.7)
Medical history
Coronary Artery Disease 463 (61.1)
Chronic Kidney Disease 280 (37.1)
Diabetes mellitus 193 (25.5)
Stroke 125 (16.5)
COPD 112 (14.8)
Anemia 111 (14.7)
Geriatric conditions
Weak Grip strength 317 (41.8)
Slow Gait speed 317 (41.8)
Cognitive impairment 264 (34.8)
Depression 296 (39.1)

Abbreviations used in this Table: ACE, angiotensin-converting enzyme; COPD, chronic obstructive pulmonary disease.

All data missing < 1% except ejection fraction (missing in 37.9% of patients), NYHA class (missing in 8.3%), ACE-inhibitor (missing in 16.6%) and Beta-blocker (missing in 16.6%).

Percentages calculated based on participants without missing data.